Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:PFE
Stock Latest News
The Fly
Pfizer presents results from Phase 2b studies of berobenatide
4h ago
PFE
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
3d ago
AZN
BMY
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
5d ago
AZN
BMY
Premium
The Fly
Moderately bullish activity in Pfizer with shares down 2.08%
6d ago
PFE
Premium
Ratings
Analyst Maintains Hold on Pfizer, Keeps Price Target Unchanged at $27 Amid Pipeline Uncertainties
7d ago
PFE
Premium
The Fly
Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri
7d ago
PFE
Premium
The Fly
Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi
8d ago
PFE
Premium
The Fly
Cboe data shows mixed options sentiment in Pfizer with shares down 0.44%
9d ago
PFE
Premium
The Fly
Pfizer announces seven-year follow-up results from Phase 3 CROWN trial
10d ago
PFE
Premium
The Fly
Pfizer enters into global strategic collaboration with Innovent Biologics
10d ago
PFE
Premium
The Fly
Cboe data shows mixed options sentiment in Pfizer with shareslittle changed
10d ago
PFE
Premium
The Fly
Guardant Health to present 38 abstracts at ASCO 2026 meeting
11d ago
GH
PFE
Premium
The Fly
Moderately bullish activity in Pfizer with shares up 1.99%
11d ago
PFE
Premium
Ratings
Pfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27
12d ago
PFE
Premium
The Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
16d ago
AZN
LLY
Premium
Ratings
Pfizer: Hold Rating Reiterated as Competitive Pressures Offset Pipeline Upside; $26 Price Target Maintained
17d ago
PFE
Premium
Ratings
Pfizer Maintained at Buy on Vaccine Franchise Strength and Pipeline Potential; $34 Price Target Reaffirmed
18d ago
PFE
Premium
The Fly
Moderately bullish activity in Pfizer with shares up 0.41%
18d ago
PFE
Premium
The Fly
Pfizer announces pneumococcal conjugate vaccine candidate data
19d ago
PFE
Premium
The Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
19d ago
AZN
BMY
Premium
The Fly
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
20d ago
AZN
BMY
Premium
The Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
23d ago
AZN
BMY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
